iatroX logo
brainstormaskiatroX
knowledge centreblog
Knowledge Centre / Allergic Bronchopulmonary Aspergillosis (ABPA)

Allergic Bronchopulmonary Aspergillosis (ABPA)

Diagnosis and management of ABPA in asthma and CF.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
RespiratoryAllergyInfectious Diseases

Clinical Guidelines

Clinical Practice Guideline for the Diagnosis and Management of Aspergillosis
Local
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
Local
Revised ISHAM-ABPA working group clinical practice guidelines for diagnosis and management of allergic bronchopulmonary aspergillosis (ABPA)
Local

Recent iatroX Q&As

  • What are the key diagnostic criteria for Allergic Bronchopulmonary Aspergillosis (ABPA) in patients with asthma?Updated: 8/22/2025
  • How should I approach the management of a patient with cystic fibrosis who develops symptoms suggestive of ABPA?Updated: 8/22/2025
  • When should I consider referring a patient with suspected ABPA to a specialist for further evaluation?Updated: 8/22/2025
  • What are the recommended treatment options for managing ABPA in patients with asthma or cystic fibrosis?Updated: 8/22/2025
askiatroX
privacytermshow it workscpdinsights
Download on the App StoreGet it on Google Play